How has PFE performed?
Pfizer (PFE) has returned about 3.0% a year over the last 25 years, with dividends reinvested and before taxes and fees. Over 10 years, the yearly figure is 4.9%. We calculate this from December 1999 through November 2026, using month-end prices adjusted for splits and dividends. Enter any amount and period in the calculator above to test your own dates.
Those averages hide a bumpy ride. The best full calendar year in our data was 2021, at 66.7%, and the worst was 2023, at -41.2%. PFE rose in 16 of 26 full calendar years. From June 2000 to February 2009, it fell 66.5% from its high, measured at month ends, which is the largest drop on record here.
Regular buying can change the picture. Putting $100 into PFE at each month end for the last 10 years would have cost $12,000 and would be worth about $14,011 today. Your own result depends on when you buy, because every purchase has a different holding period. Over the same 10 years shown above, PFE returned 4.9% a year, behind the 15.3% a year from SPY, an S&P 500 fund.
These results are historical and hypothetical, and past performance doesn't indicate future results. A single company can fall far more than the market and may never recover, so most investors keep any one stock to a small part of their portfolio. Compare PFE with other names on our stock calculator, or see how a lump sum grows at a steady rate on our investment calculator. Nothing on this page is a recommendation to buy or sell.
How we calculate PFE returns
We use month-end prices adjusted for splits and dividends, starting 1999-12-31. Change the amount, the period or the stock in the calculator above. Price data from Alpha Vantage.